Natera, Inc.

Stocks

NTRA

US6323071042

Real-time Estimate Cboe BZX Other stock markets 01:13:33 2026-06-18 pm EDT			5-day change	1st Jan Change
229.70 ^USD	+1.44%		+4.44%	-0.06%

07:06am	Natera Showcases Prospera Test Utility with 21 Presentations At American Transplant Congress	CI
Jun. 12	Natera, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-08-2026 09:20 AM

Transcript : Natera, Inc. Presents at Canaccord Genuity?s 45th Annual Growth Conference, Aug-12-2025 02

Published on 08/13/2025 at 01:21 am EDT

S&P Capital IQ

Presenter Speech
Kyle Mikson (Analysts)

I'm Kyle Mikson. I cover life science tools and diagnostics for Canaccord. Please welcome to a fireside chat with Natera here with us today. Natera is a leader

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Natera, Inc.

07:06am	Natera Showcases Prospera Test Utility with 21 Presentations At American Transplant Congress	CI
Jun. 12	Natera, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-08-2026 09:20 AM
Jun. 12	Natera MRD Leadership Supported by 'Durable' High-Value Market, RBC Says	MT
Jun. 04	Natera and CytoDyn Announces Strategic Collaboration to Advance ctDNA-Guided Development and Molecular Response Analysis in Metastatic Colorectal Cancer	CI
Jun. 03	Natera Appoints Drs. Thomas Lynch and Eric Rubin to Board of Directors	CI
May. 29	Natera, Inc. and Diakonos Oncology Corp. Announce Collaboration for Signatera in Refractory Melanoma	CI
May. 29	Natera's Signatera Selected by Diakonos Oncology for Use in Melanoma Trial	MT
May. 28	Natera Enrolls First Patients in Study Evaluating MRD-Guided Therapy for Breast Cancer	MT
May. 28	Natera Enrolls First Patients in Signal-Er 101, A Prospective, Interventional Study Evaluating Mrd-Guided Therapy in Breast Cancer	CI
May. 26	Natera Launches Enhanced Panorama Nipt Powered by Snp-Informed Deep Sequencing Technology	CI
May. 26	Natera Upgrades Prenatal Test to Improve low Fetal Fraction Accuracy	MT
May. 21	Natera Expands Operations in Austin	MT
May. 21	Natera, Inc. Expands Operations in Austin with New Sequencing Facility and Additional Lab Space	CI
May. 20	Natera Expands Enrollment in Fetal Genetic Testing Study	MT
May. 20	Expand trial of Natera's Fetal Focus single-gene NIPT surpasses >2,000 patients enrolled	RE